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1022MP-171 Beta-Blocker Use in Heart Failure: Should We Pick Up 
the Pace in Patients With Low Heart Rates? 
Eric C. Stecker, A. M. Fendrick, Bradley Knight, W. B. Fields, Keith D. Aaronson, 
University of Michigan. Ann Arbor, MI 
Background: Beta blocker (BB) therapy reduces death and hospitalizations in patients 
with CHF. However, patients with low resting heart rates (HR) are often excluded from 
BB treatment. We hypothesized that prophylactic pacemaker (PM) insertion to facilitate 
BB use in these patients would save lives at an acceptable cost. Methods: A Markov 
model simulated the natural history of a cohort of clinically stable CHF patients (EF < 
35%, mean age 60) with a resting HR of 60 bpm. Two strategies were evaluated: 1) Con- 
ventional therapy (‘conventional”) - risks of death and hospitalization were derived from 
the ACE inhibitor arm of the SOLVD treatment trial; 2) Dual chamber PM insertion and 
carvedilol therapy (“PMIBB”) - risk reductions of death and CHF-related hospitalizations 
for carvedilol compared to conventional therapy were derived from the US Cawedilol 
Study. A Cox regression model showed that baseline mortality and the death and hospi- 
talization benefits with carvedilol were independent of resting HR. For the base case, 
cawedilol benefits were assumed to persist for two years, tapered off over the next three 
years, and were gone after five years, while PM-related adverse events persisted. Costs 
and PM complication rates were based on published data, Medicare payment rates and 
average wholesale drug prices. Results: The PM/BB strategy led to an increased mean 
swvival of 1.6 years (conventional - 6.7; PM/BE - 6.3). These benefits incurred an incre- 
mental discounted cost of $6.000 (conventional - $31,000; PMlBB - 539,000). The dis- 
counted incremental cost-effectiveness for the PMIBB strategy was $6,200 per life-year 
saved. In one-way sensitwlty analyses, we varied the costs, complication rates and the 
mortality and hospitalization benefits with carvedilol between 0.5 and 1.5 of base case 
values. Results were most sensitive to changes in cost of hospitalization. cost of PM 
placement. and degree and duration of cawedilol benefit but did not exceed the econom- 
ically attractive threshold of $40,000 per life-year saved. Conclusion: Prophylactic PM 
insertion to facilitate cawedilol treatment in CHF patients with low resting HR has the 
potential to produce substantial clinical benefits at an acceptable cost. 
lo:36 a.m. 
1022MP-172 Need for Increased Referral of Minorities to Heart 
Failure Clinics 
Jacob Joseph, Yufen Huang, Paula Roberson, Roberta Monson, Jeannine Finn, lleana 
Pitia, University of Arkansas for Medical Sciences, Little Rock, AR, University Health 
System Consortium, Chicago, IL 
Racial differences in outcomes of heart failure (HF) have been postulated. We hypothe- 
sized that a nationwide survey of inpatients with HF will enable better delineation of the 
impact of racial factors, specifically delivery of care. 
Methods: We analyzed the 2000 University HealthSystem Consortium (UHC) sponsored 
survey of inpatlent HF. These surveys were done by analyzing patients admitted consec- 
utively, to UHC member hospitals (n=i 239). Baseline demographics, medication use, uti- 
lization of resources and outcomes were compared among Caucasians (C: n=701) and 
African Americans (AA: n=373). Other races were not included due to insufficient num- 
bers. 
Results: AA were significantly younger (AA 62.5 years YS C 70.5 years; p<O.OOOl). had 
more admissions due to drug noncompliance (25.7% vs. C 9.6%; P<O.OOOl), and a 
higher systolic (AA 146.6mmHg YS C 136.6 mmHg; p~O.COOl) and diastolic blood pres- 
sure (AA 62.7 mmHg vs. C 73.2mmHg; P<O.OOOl). There were no significant differences 
I” the use of anglotensin converting enzyme inhibitors, diuretics, warfarin, antiarrhyth- 
mics, inotropes or spironolactone. Beta blockade was used in less AA (15.3% vs C 
20.3%; p=O.O479). Dlgoxin use was also significantly less in AA ( 47.5% vs 56.2%; 
p=O.O07). Analysis of utilization of resources showed no significant differences in the use 
of cardiac catheterization. cardiology consultation, or HF service consultation. Referral to 
outpatient HF clinic was done in more AA (20.4%) than C (15.6%), but this trend was not 
significant (p=O.O6). Complication rates (arrhythmias, infection, stroke, renal failure, car- 
diorespiratory arrest) were similar (AA 33% vs C 33.4%). Mean length of stay (LOS) was 
lower in AA, but did not reach statistical significance (AA 5.06+/-3.43 days YS C 5.65+/- 
4.74 days) 
Conclusions: AA patients were younger with a higher rate of noncompliance, and higher 
blood pressure on admission. Interestingly, a slightly reduced LOS was observed in AA 
which Indicates the possibility of lower risk admissions (due to noncompliance and hyper- 
tenslon) preventable by aggressive HF clinic follow-up. In addition, the rates of beta- 
blockade use in both groups were low, indicating the need for aggressive follow-up. 
POSTER SESSION 
1023 Computer Applications in Procurement of 
Scientific and Evidence-Based Research 
Sunday, March 30, 2003, 9:00 a.m.-l I:00 a.m. 
McCormick Place, Hall A 
Presentation Hour: 9:00 a.m.-IO:00 a.m. 
1023-51 Micro Transducers to Profile Pulsatile Shear Stress 
With Vascular Inflammatory Responses 
Tzuna K. Hsiai, University of Southern California, Los Angeles, CA, California Institute of 
Technology, Los Angeles, CA 
Introduction: Cell-cell interactions are one of the critical events to inflammatory 
responses. The important interaction between flow regulation and cell behavior warrants 
the creation of highly sensitive but small transducers. Emergtng Micro Electra Mechani- 
cal Systems (MEMS), comparable to the size of EC with a frequency response in the kHz 
range, provide the high spatial and temporal resolution to link real-time shear stress with 
the biological activities of vascular endothelium. 
Methods and Results: MEMS shear stress sensors were operated based on the heat 
transfer principle. The heat convection from a resistively heated element to the flowing 
fluid was measured, from which a value for shear stress was inferred. A linear relation 
between V’ (voltage) and f ‘B (shear stress) can be obtained as ~/R&contains; I’ 
‘.The flow system was designed to generate well-defined temporal and spatial shear 
stress gradients. Real-time shear stress in response to pulsatile vs. oscillatory flow was 
validated with the theoretical formulation of pulsatile flow for our channel, which can be 
accessed on-line at http:liojps.aip.orglabme. Time-dependent events of monoctyesfEC 
binding kinetics in response to oscillatory shear stress (t) at + 2.6 dynlcn? were visual- 
ized with cell-tracking velocimetry. We obsewed unique trajectories of individual mono- 
@es in locomotion undergoing cell-cell binding and dissociation, followed by solid 
adhesion on EC. Our high resolution spatiotemporal analysis linked the nonlinear kinetics 
of cell-cell interactions with real-time shear stress. The values of shear stress at which 
these cell-cell interactions occurred were statistically random within the dynamic range of 
2 2.6 dyn/c&( Reynolds numbers from 0 to 22.2). 
Conclusion:The MEMS sensors offer an entry point to directly measure real-time oscil- 
latory shear stress with unprecedented temporal and spatial resolution. In a microfluidic 
environment, biochemxal mediators, not shear stress, dominated the binding affinity of 
monocytes to EC. 
1023-52 Case-Base Distance Measurements for the Selection of 
Controls in Case-Matched Studies: Application in 
Coronary Interventions 
Mariann Gvonavosi Meinhard Planer, Gerald Pore&, Wolfgang Sperker, Paul 
Wexberg, Christoph Strehblow, Dietmar Glogar, University of Vienna Medical Center, 
Vienna, Austria 
Background The main hypothesis of the presented study was that, if the matching 
baseline parameters were at least nearly perfectly selected, then the outcomes of the 
matched pairs should be simtlar, or no significant dinerewes in study outcome should be 
observed between the patients and the matched controls. 
Methods In the present study, the case-base domain was created from 1566 patients 
who had undergone intracoronary stent implantation. Uni- and multivariate logistic 
regression analysis determined 9 significant predictors (matching variables) for the 
occurrence of major adverse cardiac events. An additional 425 consecutive patients 
undergoing intracoronaly stent implantation were then matched with all the potential con- 
trols from the database by calculating the individual distance between the patient and the 
matched control on the basis of the elaborated retrieval algorithm. 
Result5 With “flexible”distance measurements, the mean distance between the patients 
and the first matched controls was 1.31. The major adverse cardiac events were com- 
pared in the patient and matched control groups. The best sensitivity and specificity val- 
ues of the matching system could be achieved in matched pairs with the distancg3 
(95.1% of all patients). On the further stepwise exclusion of the matched pairs exhibiiing 
a distance greater than 2 and 1, then the number of “matchable” controls and the speci- 
ficity of our matching concept decreased considerably. When the short- or mid-term out- 
come was compared by using the long-term follow-up matching parameters, no 
correlation could be found between the treated subjects and controls, nndtcating, that for 
other study main measures other appropriate parameters must be selected. Further- 
more, the outcome measures of the patients and randomly (non-systematically) selected 
controls did not correlate, revealing the impossibility of drawing correct study conclusions 
from a non-matched. randomly assigned pairs. Conclusion The sensitivity and specific- 
ity of the matching program and the study conclusions depend on the appropriately pre- 
defined matching parameters and retrieval algorithm. 
1023-53 Automatic Correction of Pressure Distortion by Fluid- 
Filled Systems: A Novel Statistical Frequency Domain 
Approach 
Ernst Wellnhofer, Juergen Hug, Evgeni Potapov, Bertin Bluemcke, Eckarl Fleck, DHZB, 
Berlin, Germany 
The aim of the study was to develop an automatic correction of the pressure errors 
resulting from fluid-filled catheter systems (FFS) with the catheter in place and without 
disturbing running measurements. 
